ConductScience.org, home

Trial · NCT02311543

Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer

NCT02311543, Phase 3, Completed, Swiss Cancer Institute

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer. Trials, record NCT02311543. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02311543

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer
NCT number
NCT02311543
Status
Completed
Phases
Phase 3
Enrollment
142 participants, actual
Lead sponsor
Swiss Cancer Institute
Conditions
Breast Cancer
Interventions
TachoSil® patches
First posted
2014-12-08
Last updated
2019-05-15

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTotal volume of axillary drainageuntil drain removal (2 - 10 days after surgery)Total volume of axillary drainage in ml until drain removal.
SecondaryVolume of axillary drainage per 24 hoursuntil drain removal (2 - 10 days after surgery)Volume of axillary drainage per 24 hours in ml will be calculated as the total volume of axillary drainage in ml until drain removal divided by the total duration of axillary drainage in days
SecondaryTotal duration of axillary drainage in daysuntil drain removal (2 - 10 days after surgery)Total duration of axillary drainage in days will be calculated from the date of surgery to the date of axillary drain removal
SecondaryDuration of postoperative hospital stay in daysbetween 3-6 days after surgeryDuration of postoperative hospital stay in days will be calculated from the date of surgery to the date of hospital discharge.
SecondaryPatients with clinically relevant seromauntil 24 weeks after surgeryClinically relevant seroma is defined as either causing discomfort or requiring aspiration.
SecondaryNumber of clinically relevant seroma aspirationsuntil 24 weeks after surgeryNumber of clinically relevant seroma aspirations until 24 weeks after surgery
SecondaryTotal volume of all clinically relevant seroma aspirations in mluntil 24 weeks after surgeryTotal volume of all clinically relevant seroma aspirations in ml until 24 weeks after surgery

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
29948418RESULT

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02311543

GET https://conductscience.org/api/trials/v1/NCT02311543/registered